Analysis of OncoTherapy Science, Inc. (4564)
OncoTherapy Science, Inc. is showing some interesting trends based on the provided data. Here are a few key points from the analysis:
1. **Price Movement**: The price of OncoTherapy Science, Inc. has been fluctuating over the past few days, ranging from a low of 15.00000 to a high of 34.00000. This indicates volatility in the stock.
2. **Technical Indicators**:
- **RSI Indicator**: The Relative Strength Index (RSI) values have been fluctuating between 35.79672 and 80.56454, indicating some level of volatility in the stock's price movements.
- **MACD Indicator**: The Moving Average Convergence Divergence (MACD) values have been positive, with the MACD line consistently above the signal line, suggesting a bullish trend.
3. **Moving Averages**:
- The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values have been increasing over the past few days, indicating a potential uptrend in the stock price.
4. **Overall Sentiment**:
- The stock seems to be on an upward trend based on the moving averages and MACD indicator. However, the RSI values suggest that the stock may be approaching overbought levels.
5. **Recommendation**:
- Investors may want to closely monitor the stock for a potential buying opportunity if the price consolidates or retraces slightly. It is important to consider the risk of a potential pullback given the recent price volatility.
This analysis provides a snapshot of the recent performance of OncoTherapy Science, Inc. It is important to conduct further research and analysis before making any investment decisions.
Income statement 💸
These are the revenues. Draw conclusions.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in leases, land, and improvements, reflecting a growth strategy.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. Long-term debt is a major component of non-current liabilities, requiring attention for long-term financial stability.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provides a comprehensive overview of the financials, stock statistics, valuations metrics, stock price summary, and dividends and splits for a particular company.
1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320, and levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a most recent quarter (MRQ) basis is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets (TTM)**: 22.073999%.
- **Return on Equity (TTM)**: 147.25%.
2. **Stock Statistics**:
- **Short Ratio**: 1.53.
- **Float Shares**: 15,308,320,742.
- **Shares Short**: 99,287,450.
- **Average 10-Day Volume**: 46,860,048.
- **Average 90-Day Volume**: 57,498,254.
- **Shares Outstanding**: 15,334,099,968.
- **Percent Held by Insiders**: 5.22%.
- **Percent Held by Institutions**: 57.589%.
- **Short Percent of Shares Outstanding**: 0.65%.
3. **Valuations Metrics**:
- **PEG Ratio**: 26.319502.
- **Forward PE**: 26.319502.
- **Trailing PE**: 29.59409.
- **Enterprise Value**: $2,950,762,332,160.
- **Price to Book MRQ**: 39.3405.
- **Price to Sales TTM**: 7.646095.
- **Enterprise to EBITDA**: 22.763.
- **Enterprise to Revenue**: 7.732.
- **Market Capitalization**: $2,917,925,650,432.
4. **Stock Price Summary**:
- **Beta**: 1.264.
- **50-Day Moving Average**: $176.2646.
- **200-Day Moving Average**: $181.0429.
- **52-Week Low**: $164.08.
- **52-Week High**: $199.62.
- **52-Week Change**: 6.853%.
5. **Dividends and Splits**:
- **Payout Ratio**: 14.93%.
- **Dividend Date**: May 16, 2024.
- **Last Split Date**: August 31, 2020.
- **Ex-Dividend Date**: May 10, 2024.
- **Last Split Factor**: 4-for-1 split.
- **Forward Annual Dividend Rate**: $1.
- **5-Year Average Dividend Yield**: 0.73%.
- **Forward Annual Dividend Yield**: 0.5255%.
- **Trailing Annual Dividend Rate**: $0.97.
- **Trailing Annual Dividend Yield**: 0.5097%.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.
For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same period last year. The number of analysts providing estimates is 25.
Looking at the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate for total sales is $357,772,000,000, showing a 1% growth compared to the previous fiscal year. The number of analysts providing estimates increases to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate further increases to $380,772,000,000, with a significant growth rate of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly increasing number of analysts providing forecasts.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to have a compound annual growth rate (CAGR) of 11%.
- However, when comparing to the past 5 years, where the company had a CAGR of 20.1%, the future growth rate is expected to be lower.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly lower growth rate compared to the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price of the security is $191.57, which is below the median and average forecasted prices.MACD of 4564